drugIndia
Cart
Glimestar-PM2 Tablet ER

Glimestar-PM2 Tablet ER

Metformin (500mg) + Glimepiride (2mg) + Pioglitazone (15mg)

Mankind Pharma Ltd
Hypertension
93.74117.1820% OFF
In Stock
1
Safe & Secure
Easy Returns
24/7 Support
Delivery
drugIndia verified
Save 74%
Best Alternative100% Match

Glynet-PM2 Tablet ER

Zeelab Pharmacy Pvt Ltd

Pioglitazone 15mg
Glynet-PM2 Tablet ER

Pack Size

1 units

Price

24.0020% off
Glynet-PM2 Tablet ER is 100% same as Glimestar-PM2 Tablet ER
Better ValueSame QualitySame Effectiveness

Save ₹70

that's 74% off!

composition
  1. Pioglitazone 15mg
  2. Glimepiride 2mg
  3. Metformin 500mg
Buy Now
93.7420% OFF
117.18

About This Medicine

Product description & overview

Glimestar-PM2 Tablets ER: A Comprehensive Treatment Solution

Glimestar-PM2 Tablets Extended Release (ER) combines three powerful medications – Glimepiride, Metformin, and Pioglitazone – to manage type 2 diabetes effectively. Each tablet offers a precise dosage of these essential components for optimal blood sugar control:

* Glimepiride (2mg): A sulfonylurea medication that stimulates insulin secretion from the pancreas, lowering blood glucose levels.
* Metformin (500mg): A first-line drug for type 2 diabetes, it improves insulin sensitivity and reduces hepatic glucose production, further contributing to improved glycemic control.
* Pioglitazone (15mg): An antidiabetic medication that acts as a thiazolidinedione, increasing the body's uptake of glucose from the liver and tissues, helping lower blood sugar levels.

This combination provides comprehensive glycemic management for patients with type 2 diabetes. Glimestar-PM2 Tablets ER offers extended-release technology, ensuring consistent drug delivery throughout the day.

Please consult a healthcare professional before starting any new medication regimen.

Active composition

Metformin 500 mg

+2 more active ingredients

About Metformin

Metformin is an oral antihyperglycemic agent used to manage type 2 diabetes mellitus. It works by decreasing glucose production in the liver and improving insulin sensitivity. Metformin is effective in controlling blood sugar levels and preventing diabetes-related complications. In summary, Metformin is vital for managing type 2 diabetes.

How It Works

Metformin reduces hepatic glucose production and enhances peripheral insulin sensitivity, lowering blood glucose levels.

Medicine Strength
500 mg

All Active Ingredients

Metformin500 mg
Glimepiride2 mg
Pioglitazone15 mg

Glimepiride

Glimepiride stimulates insulin secretion from pancreatic beta cells and enhances insulin sensitivity in peripheral tissues, facilitating glucose uptake and lowering blood sugar levels.

Pioglitazone

Pioglitazone activates peroxisome proliferator-activated receptor gamma (PPAR-γ), enhancing insulin sensitivity and glucose metabolism.

Dosage & How to Use

Dosage information not available. Please consult your doctor or pharmacist.

Safety Advice

Important precautions

Side Effect Occurrence

Based on clinical trials and patient reports.

Overall Tolerance

Most patients tolerate well

Only 2.3% reported effects

Common Side Effects

Headache8%
Nausea5%
Dizziness3%
Fatigue2%
Rash1%
Higher
Lower

Safety Advice

Alcohol

It is unsafe to consume alcohol with Glimestar-PM2 Tablet ER.

High Risk

Pregnancy

Glimestar-PM2 Tablet ER may be unsafe to use during pregnancy. Although there are limited studies in humans, animal studies have shown harmful effects on the developing baby. Your doctor will weigh the benefits and any potential risks before prescribing it to you. Please consult your doctor.

Medical Advice

Driving

Your ability to drive may be affected if your blood sugar is too low or too high. Do not drive if these symptoms occur.

Exercise Caution

Liver

Glimestar-PM2 Tablet ER should be used with caution in patients with liver disease. Dose adjustment of Glimestar-PM2 Tablet ER may be needed. Please consult your doctor. Use of Glimestar-PM2 Tablet ER is not recommended in patients with severe liver disease.

Regular Checkup

Breastfeeding

Glimestar-PM2 Tablet ER is probably unsafe to use during breastfeeding. Limited human data suggests that the drug may pass into the breastmilk and harm the baby.

Consult Doctor

Kidney

Glimestar-PM2 Tablet ER should be used with caution in patients with kidney disease. Dose adjustment of Glimestar-PM2 Tablet ER may be needed. Please consult your doctor. Use of Glimestar-PM2 Tablet ER is, however, not recommended in patients with severe kidney disease. Regular monitoring of kidney function test is advisable while you are taking this medicine.

Regular Checkup

Customer Reviews

0 reviews for Glimestar-PM2 Tablet ER

Products matching your search